The effects of selenium supplementation on clinical outcomes in mechanically ventilated, non-surgical/traumatic critically ill patients

Authors

Kamran HeydariKamran Heydari ORCID1,*, Mojtaba Mansouri2, Masoome Lakestani1, Mohammadreza HajiesmaeiliMohammadreza Hajiesmaeili ORCID2
1Emergency Medicine, Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran,
2Anesthesiology and Critical Care Medicine, Neurocritical Care Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran
*Corresponding Author: Emergency Medicine, Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Email: [email protected]

Journal of Cellular & Molecular Anesthesia:Vol. 3, issue 2; e149558
Published online:Sep 02, 2018
Article type:Original Articles
How to Cite:Heydari K, Mansouri M, Lakestani M, Hajiesmaeili M. The effects of selenium supplementation on clinical outcomes in mechanically ventilated, non-surgical/traumatic critically ill patients. J Cell Mol Anesth. 2018;3(2):e149558. doi: https://doi.org/10.22037/jcma.v3i2.20739

Abstract

Background: Selenium presents anti-inflammatory and antioxidant properties which plays a critical role in nutrition of patients following devastating conditions. Furthermore, several lines of evidence reported that most of patients who admitted to intensive care unit (ICU) have lower plasma levels of selenium. Therefore, this study was designed to define the impact of selenium supplementation on clinical outcomes of mechanically ventilated non-surgical/traumatic critically ill patients.Materials and Methods: This study was conducted on 105 subjects hospitalized in ICU of Shohadaye Haft-e Tir Hospital, Tehran, Iran. Here the acute physiologic assessment and chronic health evaluation (APACHE) II score of patients was documented on the day of their ICU admission. The patients were divided to two groups based on block randomization technique and were assigned to receive selenium or placebo. Then the effect of selenium supplementation was evaluated based on the APACHE II score, the occurrence of ventilator associated pneumonia (VAP), length of ICU stay and the rate of mortality.Results: The acquired data revealed no significant difference between two experimental groups based on the demographical information. Also it was demonstrated that selenium supplementation of critically ill patients was associated with better APACHE II score, fewer length of ICU stay and fewer mortality rate. Incidence of VAP indicated no significant difference between groups.Conclusion: The obtained data of this single center clinical trial showed that selenium supplementation could improve clinical outcomes of critically ill patients.Keywords: Selenium supplementation; APACHE II score; ventilator associated pneumonia; mortality rate; length of ICU stay

References

  • 1.
    References are in the PDF file of the article.

Copyright

© 2018, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

24
Apr
2015

The effect of selenase on the disease process of patients with septic shock admitted to the intensive care unit: A clinical trial in Tehran

Ebrahim Hazrati,
Mohammad Reza Rafii Rafii,
behzad kazemi haki,
Babak Shekarchi,
Seyed Javad Hosseini-Shokouh

Hazrati E, Rafii MRR, kazemi haki B, Shekarchi B, Hosseini-Shokouh SJ. The effect of selenase on the disease process of patients with septic shock admitted to the intensive care unit: A clinical trial in Tehran. Ann Mil Health Sci Res. 2015;13(1):e62678. doi:

10
Jun
2020
Effects of High-Dose Selenium Supplementation on Oxidative Stress and Inflammatory Markers in Critically Ill Children After Gastrointestinal Surgery: A Randomized Clinical Trial

Effects of High-Dose Selenium Supplementation on Oxidative Stress and Inflammatory Markers in Critically Ill Children After Gastrointestinal Surgery: A Randomized Clinical Trial

Fatemeh Roudi,
Gholamreza Khademi,
Golnaz Ranjbar,
Houshang Rafatpanah,
Habibollah Esmaily,
Mohsen Nematy

Roudi F, Khademi G, Ranjbar G, Rafatpanah H, Esmaily H, et al. Effects of High-Dose Selenium Supplementation on Oxidative Stress and Inflammatory Markers in Critically Ill Children After Gastrointestinal Surgery: A Randomized Clinical Trial. Inn J Pediatr. 2020;30(4):e102118. doi: https://doi.org/10.5812/ijp.102118

25
Sep
2023
Safety and Efficacy of Selenium on Recovery of Hospitalized Patients with COVID-19: A Randomized Controlled Clinical Trial

Safety and Efficacy of Selenium on Recovery of Hospitalized Patients with COVID-19: A Randomized Controlled Clinical Trial

Elham Shafiei,
Golnaz Mahmoudvand,
Arian Karimi Rouzbahani,
Ali Nazari

Shafiei E, Mahmoudvand G, Karimi Rouzbahani A, Nazari A. Safety and Efficacy of Selenium on Recovery of Hospitalized Patients with COVID-19: A Randomized Controlled Clinical Trial. Arch Clin Infect Dis. 2023;18(4):e137390. doi: https://doi.org/10.5812/archcid-137390

20
Feb
2015

What is the Optimal Dose of Selenium and Other Antioxidants in Critically Ill Patients?

Reza Mosaed,
Mohammad Hosein Ghadimi,
Mojtaba Mojtahedzadeh,
Arezoo Ahmadi

Mosaed R, Ghadimi MH, Mojtahedzadeh M, Ahmadi A. What is the Optimal Dose of Selenium and Other Antioxidants in Critically Ill Patients?. J Arch Mil Med. 2015;3(1):e26080. doi: https://doi.org/10.5812/jamm.26080

31
Oct
2011

The Relationship Between Vitamin E Plasma and BAL Concentrations, SOD Activity and Ventilatory Support Measures in Critically Ill Patients

Shadi Ziaie,
Hamidreza Jamaati,
Mannan Hajimahmoodi,
Seyyed Mohammadreza Hashemian,
Fanak Fahimi,
Behrooz Farzanegan
,et al.

Ziaie S, Jamaati H, Hajimahmoodi M, Hashemian SM, Fahimi F, et al. The Relationship Between Vitamin E Plasma and BAL Concentrations, SOD Activity and Ventilatory Support Measures in Critically Ill Patients. Iran J Pharm Res. 2011;10(4):e126003. doi: https://doi.org/10.22037/ijpr.2011.983

More by these authors

Kamran HeydariPubMedScholar
Mojtaba MansouriPubMedScholar
Masoome LakestaniPubMedScholar
Mohammadreza HajiesmaeiliPubMedScholar
Share
Cited by
Metrics